Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-11
DOI
10.3389/fcvm.2020.00143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
- (2020) Philippe Colson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
- (2020) Fang Jiang et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- SARS-CoV-2 perturbs the Renin-Angiotensin System and energy metabolism
- (2020) Jun Mori et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- COVID-19, ACE2, and the cardiovascular consequences
- (2020) Andrew M. South et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection
- (2020) Roberto Gnavi et al. CLINICAL INFECTIOUS DISEASES
- Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study
- (2020) Sun-Young Jung et al. CLINICAL INFECTIOUS DISEASES
- SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
- (2020) Gabriela M Kuster et al. EUROPEAN HEART JOURNAL
- Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020
- (2020) Marta Colaneri et al. Eurosurveillance
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
- (2020) Ankit B. Patel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
- (2020) Hao Cheng et al. JOURNAL OF MEDICAL VIROLOGY
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
- (2020) Elissa Driggin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
- (2020) Francisco J de Abajo et al. LANCET
- Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
- (2020) Jean-Jacques Mourad et al. Nature Reviews Cardiology
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
- (2020) Juyi Li et al. JAMA Cardiology
- Response by Zhang et al to Letter Regarding Article, “Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19”
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study
- (2020) Chao Gao et al. EUROPEAN HEART JOURNAL
- A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
- (2020) Andrea Cortegiani et al. JOURNAL OF CRITICAL CARE
- Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis
- (2020) Sakiko Tabata et al. LANCET INFECTIOUS DISEASES
- The Renin-Angiotensin System: Going Beyond the Classical Paradigms
- (2019) Robson A. Souza Santos et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?
- (2019) Annamaria Mascolo et al. HEART FAILURE REVIEWS
- Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
- (2018) Brian P Halliday et al. LANCET
- New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases
- (2017) A Mascolo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
- (2017) Ratnadeep Basu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?
- (2016) Mark C. Chappell AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
- (2016) Hongjing Gu et al. Scientific Reports
- Human monocyte subsets exhibit divergent angiotensin I-converting activity
- (2015) M. Rutkowska-Zapała et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Arbidol as a broad-spectrum antiviral: An update
- (2014) Julie Blaising et al. ANTIVIRAL RESEARCH
- Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
- (2014) Zhen Zou et al. Nature Communications
- Tissue Renin–Angiotensin Systems: A Unifying Hypothesis of Metabolic Disease
- (2014) Jeppe Skov et al. Frontiers in Endocrinology
- Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms
- (2013) A. O. Adedeji et al. JOURNAL OF VIROLOGY
- Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system
- (2012) Robson A S Santos et al. JOURNAL OF ENDOCRINOLOGY
- Characterization of Angiotensin-(1–7) effects on the cardiovascular system in an experimental model of Type-1 diabetes
- (2012) Mariam H.M. Yousif et al. PHARMACOLOGICAL RESEARCH
- Macrophage Polarization by Angiotensin II-Type 1 Receptor Aggravates Renal Injury-Acceleration of Atherosclerosis
- (2011) Suguru Yamamoto et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist
- (2011) Roelie M Wösten-van Asperen et al. JOURNAL OF PATHOLOGY
- Anti-Inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, Mas, in Experimental Models of Arthritis
- (2010) K. D. da Silveira et al. JOURNAL OF IMMUNOLOGY
- Interaction between Fibrinogen and IL-6 Genetic Variants and Associations with Cardiovascular Disease Risk in the Cardiovascular Health Study
- (2009) Cara L. Carty et al. ANNALS OF HUMAN GENETICS
- Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction
- (2009) Zamaneh Kassiri et al. Circulation-Heart Failure
- SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
- (2009) G. Y. Oudit et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
- Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes
- (2008) Marco F. Dias-Peixoto et al. HYPERTENSION
- Unknown
- (2008) Rodrigo Fraga-Silva et al. MOLECULAR MEDICINE
- Role of the renin–angiotensin system in vascular inflammation
- (2008) Chiara Marchesi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now